Blood, lymphoid tissues and haemopoiesis

Published on 17/03/2015 by admin

Filed under Basic Science

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2666 times

CHAPTER 4 Blood, lymphoid tissues and haemopoiesis

In postnatal life blood cells are formed in the bone marrow. Haemopoiesis produces red cells (erythrocytes), and a wide variety of defensive cells (white blood cells, or leukocytes). The latter include neutrophil, eosinophil and basophil granulocytes, B lymphocytes and monocytes. T lymphocytes develop in the thymus from bone marrow-derived progenitors. Platelets are produced in the bone marrow as cellular fragments of megakaryocytes. Only erythrocytes and platelets are generally confined to the blood vascular system, whereas all leukocytes can leave the circulation and enter extravascular tissues. The numbers of cells doing so increases greatly during inflammation caused by local infections and diseases.

The lymphoid tissues are the thymus, lymph nodes, spleen and the lymphoid follicles associated mainly with the alimentary and respiratory tracts. Lymphocytes populate lymphoid tissues and are concerned with various types of immune defence. Lymphoid tissue also contains supportive stromal cells which are non-haemopoietic in origin (e.g. thymic epithelium), non-haemopoietic follicular dendritic cells of lymph nodes and splenic follicles, haemopoietically-derived interdigitating dendritic cells, and macrophages of the mononuclear phagocyte system. Dendritic cells and blood monocyte-derived macrophages are found additionally in most tissues and organs where they function as immunostimulatory antigen-presenting cells (APCs).

CELLS OF PERIPHERAL BLOOD

BLOOD

Blood is an opaque fluid with a viscosity greater than that of water (mean relative viscosity 4.75 at 18°C), and a specific gravity of 1.06 at 15°C. It is bright red when oxygenated, in the systemic arteries, and dark red to purple when deoxygenated, in systemic veins. Blood is a mixture of a clear liquid, plasma, and cellular elements, and consequently the hydrodynamic flow of blood in vessels behaves in a complex manner that is not entirely predictable by simple Newtonian equations.

Plasma

Plasma is a clear, yellowish fluid which contains many substances in solution or suspension: low molecular weight solutes give a mean freezing-point depression of 0.54°C. Plasma contains high concentrations of sodium and chloride ions, potassium, calcium, magnesium, phosphate, bicarbonate, traces of many other ions, glucose, amino acids and vitamins. The colloids include high molecular weight plasma proteins, e.g. clotting factors, particularly prothrombin; immunoglobulins and complement proteins involved in immunological defence; glycoproteins, lipoproteins, polypeptide and steroid hormones and globulins for the transport of hormones and iron. Since most of the metabolic activities of the body are reflected in the plasma composition, its routine chemical analysis is of great diagnostic importance.

The precipitation of the protein fibrin from plasma to form a clot (Fig. 4.1) is initiated by the release of specific materials from damaged cells and blood platelets in the presence of calcium ions. If blood or plasma samples are allowed to stand, they will separate into a clot and a clear yellowish fluid, the serum. Clot formation is prevented by removal of calcium ions, e.g. by addition of citrate, oxalate or various organic calcium chelators (EDTA, EGTA) to the sample. Heparin is also widely used as an anticlotting agent, because it interferes with another part of the complex series of chemical interactions which lead to fibrin clot formation.

ERYTHROCYTES

Erythrocytes (red blood cells, red blood corpuscles [RBC]) account for the largest proportion of blood cells (99% of the total number), with normal values of 4.1–6.0 × 106/μl in adult males and 3.9–5.5 × 106/μl in adult females. Polycythaemia (increased red cell mass) can occur in individuals living at high altitude, or pathologically in conditions resulting in arterial hypoxia. Reduction in red cell mass (anaemia) has many underlying causes but in rare instances can be due to structural defects in erythrocytes (see below).

Each erythrocyte is a biconcave disc (Fig. 4.1, Fig. 4.2) with a mean diameter in dried smear preparations of 7.1 μm; in fresh preparations the mean diameter is 7.8 μm, decreasing slightly with age. Mature erythrocytes lack nuclei. They are pale red by transmitted light, with paler centres because of their biconcave shape. The properties of their cell coat cause them to adhere to one another by their rims to form loose piles of cells (rouleaux). In normal blood, a few cells assume a shrunken star-like, crenated form: this shape can be reproduced by placing normal biconcave erythrocytes in a hypertonic solution, which causes osmotic shrinkage. In hypotonic solutions erythrocytes take up water and become spherical; they may eventually lyse to release their haemoglobin (haemolysis), leaving red cell ghosts.

Erythrocytes have a limiting plasma membrane which encloses mainly a single protein, haemoglobin, as a 33% solution. The plasma membrane of erythrocytes is 60% lipid and glycolipid, and 40% protein and glycoprotein. More than 15 classes of protein are present, including two major types. Glycophorins A and B (each with a molecular mass of approximately 50 kDa) span the membrane, and their negatively charged carbohydrate chains project from the outer surface of the cell. Their sialic acid groups confer most of the fixed charge on the cell surface. A second transmembrane macromolecule, band 3 protein, forms an important anion channel, exchanging bicarbonate for chloride ions across the membrane and allowing the release of CO2 in the lungs. The ABO blood group antigens are all membrane glycolipids.

The shape of the erythrocyte is largely determined by the filamentous protein dimer, spectrin, a name which reflects its original isolation from red cell ghosts. Spectrin dimers associate as tetramers through their head regions, and are attached to the cytoplasmic domain of the anion carrier, band 3 protein, via ankyrin. Other proteins, including tropomyosin, tropomodulin and short actin filaments form junctional complexes which link spectrin to glycophorin transmembrane proteins, forming a stabilizing cytoskeletal network. This gives the membrane great flexibility: red cells are deformable but regain their biconcave shape and dimensions after passing through the smallest capillaries, which are 4 μm in diameter. Erythrocyte membrane flexibility also contributes to the normally low viscosity of blood. Defects in the cytoskeleton occur in autosomal dominant disorders (some cases of elliptocytosis result from mutations in spectrin and of spherocytosis from ankyrin dysfunction) which result in abnormalities of red cell shape, membrane fragility, premature destruction of erythrocytes in the spleen and haemolytic anaemia.

Fetal erythrocytes up to the fourth month of gestation differ markedly from those of adults, in that they are larger, are nucleated and contain a different type of haemoglobin (HbF). After this time they are progressively replaced by the adult type of cell.

Haemoglobin

Haemoglobin (Hb) is a globular protein with a molecular mass of 67 kDa. It consists of globulin molecules bound to haem, an iron-containing porphyrin group. The oxygen-binding power of haemoglobin is provided by the iron atoms of the haem groups, and these are maintained in the ferrous (Fe++) state by the presence of glutathione within the erythrocyte. The haemoglobin molecule is a tetramer, made up of four subunits, each a coiled polypeptide chain holding a single haem group. In normal blood, five types of polypeptide chain can occur, namely; α, β and two β-like polypeptides, γ and δ. A third, β-like η chain is restricted to early fetal development. Each haemoglobin molecule contains two α-chains and two others, so that several combinations, and hence a number of different types of haemoglobin molecule, are possible. For example, haemoglobin A (HbA), which is the major adult class, contains 2α- and 2β-chains; a variant, HbA2 with 2α and 2δ chains, accounts for only 2% of adult haemoglobin. Haemoglobin F (HbF), found in fetal and early postnatal life, consists of 2α- and 2γ-chains. Adult red cells normally contain less than 1% of HbF.

In the pathological genetic condition thalassaemia, only one type of chain is expressed normally, the mutant chain being absent or present at much reduced levels. Thus, a molecule may contain 4 α-chains (β-thalassaemia) or, more commonly, 4 β-chains (α-thalassaemia) where individuals affected carry haemoglobin H (HbH). In haemoglobin S (HbS) of sickle-cell disease, a point mutation in the β-chain gene (valine substituted for glutamine) causes a major alteration in the behaviour of the red cell and its oxygen-carrying capacity.

Lifespan

Erythrocytes last between 100 and 120 days before being destroyed. As erythrocytes age they become increasingly fragile, and their surface charges decrease as their content of negatively charged membrane glycoproteins diminishes. The lipid content of their membranes also reduces. Aged erythrocytes are eventually ingested by the macrophages of the spleen and liver sinusoids, usually without prior lysis, and are hydrolysed in phagocytic vacuoles where the haemoglobin is split into its globulin and porphyrin moieties. Globulin is further degraded to amino acids which pass into the general amino acid pool. Iron is removed from the porphyrin ring and either transported in the circulation bound to transferrin and used in the synthesis of new haemoglobin in the bone marrow, or stored in the liver as ferritin or haemosiderin. The remainder of the haem group is converted in the liver to bilirubin and excreted in the bile.

The recognition of effete erythrocytes by macrophages appears to depend in part on the exposure of normally inaccessible parts of membrane proteins, enabling autoantibodies to these erythrocyte senescence antigens to bind to them and flag them for macrophage removal. Red cells are destroyed at the rate of 5 × 1011 cells a day and are normally replaced from the bone marrow (see Fig. 4.12) at the same rate.

Blood groups

Over 300 red cell antigens are recognizable with specific antisera. They can interact with naturally occurring or induced antibodies in the plasma of recipients of an unmatched transfusion, causing agglutination and lysis of the erythrocytes. Erythrocytes of a single individual can carry several different types of antigen, each type belonging to an antigenic system in which a number of alternative antigens are possible in different persons. So far, 19 major groups have been identified. They vary in their distribution frequencies between different populations, and include the ABO, Rhesus, MNS, Lutheran, Kell, Lewis, Duffy, Kidd, Diego, Cartwright, Colton, Sid, Scianna, Yt, Auberger, Ii, Xg, Indian and Dombrock systems. Clinically, the ABO and Rhesus groups are of most importance.

In the ABO system, two allelic genes are inherited in simple Mendelian fashion. Thus the genome may be homozygous and carry the AA complement, the blood group being A, or the BB complement which gives blood group B, or it may carry neither (OO), producing blood group O. In the heterozygous condition the following combinations can occur: AB (blood group AB), AO (blood group A) and BO (blood group B).

Individuals with group AB blood lack antibodies to both A and B antigens, and so can be transfused with blood of any group: they are termed universal recipients. Conversely, those with group O, universal donors, can give blood to any recipient, since anti-A and anti-B antibodies in the donated blood are diluted to insignificant levels. Normally, however, blood is only transfused between persons with precisely corresponding groups, because anomalous antibodies of the ABO system are occasionally found in blood and may cause agglutination or lysis. The anti-ABO agglutinins, unlike those of the Rhesus system, belong to the immunoglobulin M (IgM) class and do not cross the placenta during pregnancy.

The Rhesus antigen system is determined by three sets of alleles, namely Cc, Dd and Ee: the most important clinically is Dd. Inheritance of the Rh factor also obeys simple Mendelian laws and it is therefore possible for a Rhesus-negative mother to bear a Rhesus-positive child. Fetal Rh antigens can, under these circumstances, stimulate the production of anti-Rh antibodies by the mother: since these belong to the immunoglobulin G (IgG) class of antibodies they are able to cross the placental barrier (generally late in the last trimester) and cause agglutination of fetal erythrocytes. In the first such pregnancy little damage usually occurs because anti-Rh antibodies are present only at low levels, but in subsequent Rh-positive pregnancies massive destruction of fetal red cells (haemolytic disease of the newborn) may result, causing fetal or neonatal death. Sensitization of the maternal immune system can also result from abortion or miscarriage, or even occasionally amniocentesis, which may introduce fetal antigens into the maternal circulation. Treatment is by exchange transfusion of the neonate or, prophylactically, by giving Rh-immune (anti-D) serum to the mother after the first Rh-positive pregnancy, which destroys the fetal Rh antigen in her circulation before sensitization can occur.

Leukocytes also bear highly polymorphic antigens encoded by allelic gene variants. These belong to the group of major histocompatibility complex (MHC) antigens, also termed human leukocyte antigens (HLA) in man. HLA Class I antigens are expressed by all nucleated cells. Class II antigen expression is more restricted outside the immune system, but is inducible on many parenchymal cell types e.g. after exposure to interferon. HLA Class I and II antigens play important roles in cell–cell interactions in the immune system, particularly in the presentation of antigens to T lymphocytes by APCs.

LEUKOCYTES

Leukocytes (white blood cells) belong to at least five different categories (see Fig. 4.12), and are distinguishable by their size, nuclear shape and cytoplasmic inclusions. In practice, leukocytes are often divided into two main groups, namely those with prominent stainable cytoplasmic granules, the granulocytes, and those without.

Granulocytes

This group consists of eosinophil granulocytes, with granules which bind acidic dyes such as eosin; basophil granulocytes, with granules which bind basic dyes strongly; and neutrophil granulocytes, with granules which stain only weakly with either type of dye. Granulocytes (Fig. 4.3) all possess irregular or multilobed nuclei and belong to the myeloid series of blood cells (p. 77 see Fig. 4.12).

Neutrophil granulocytes

Neutrophil granulocytes (neutrophils), are also referred to as polymorphonuclear leukocytes (polymorphs) because of their irregularly segmented (multilobed) nuclei. They form the largest proportion of the white blood cells (40–75% in adults, with a normal count of 2500–7500/μl) and have a diameter of 12–14 μm. The cells may be spherical in the circulation, but they can flatten and become actively motile within the extracellular matrix of connective tissues.

The numerous cytoplasmic granules are heterogeneous in size, shape and content, but all are membrane-bound and contain hydrolytic and other enzymes. Two major types can be distinguished according to their developmental origin and contents. Non-specific or primary (azurophilic) granules are formed early in neutrophil maturation. They are relatively large (0.5 μm) spheroidal lysosomes containing myeloperoxidase, acid phosphatase, elastase and several other enzymes. Specific or secondary granules are formed later, and occur in a wide range of shapes including spheres, ellipsoids and rods. These contain strong bacteriocidal components including alkaline phosphatase, lactoferrin and collagenase, none of which are found in primary granules. Conversely, secondary granules lack peroxidase and acid phosphatase. Some enzymes, e.g. lysozyme, are present in both types of granule.

In mature neutrophils the nucleus is characteristically multilobed with up to six (usually three or four) segments joined by narrow nuclear strands: this is known as the segmented stage. Less mature cells have fewer lobes. The earliest to be released under normal conditions are juveniles (band or stab cells) in which the nucleus is an unsegmented crescent or band. In certain clinical conditions, even earlier stages in neutrophil formation, when cells display indented or rounded nuclei (metamyelocytes or myelocytes) may be released from the bone marrow. In mature cells the edges of the nuclear lobes are often irregular. In females 3% of the nuclei of neutrophils show a conspicuous ‘drumstick’ formation which represents the sex chromatin of the inactive X chromosome (Barr body). Neutrophil cytoplasm contains few mitochondria but abundant cytoskeletal elements, including actin filaments, microtubules and their associated proteins, all characteristic of highly motile cells.

Neutrophils are important in the defence of the body against microorganisms. They can phagocytose microbes and small particles in the circulation and, after extravasation, they carry out similar activities in other tissues. They function effectively in relatively anaerobic conditions, relying largely on glycolytic metabolism, and they fulfil an important role in the acute inflammatory phase of tissue injury, responding to chemotaxins released by damaged tissue. Phagocytosis of cellular debris or invading microorganisms is followed by fusion of the phagocytic vacuole, first with specific granules, whose pH is reduced to 5.0 by active transport of protons, then with non-specific (primary) granules, which complete the process of bacterial killing and digestion. Actively phagocytic neutrophils are able to reduce oxygen enzymatically to form reactive oxygen species including superoxide radicals and hydrogen peroxide, which enhance bacterial destruction.

Phagocytosis is greatly facilitated by circulating antibodies to molecules such as bacterial antigens which the body has previously encountered. Antibodies coat the antigenic target and bind the plasma complement protein, C1, to their non-variable Fc regions. This activates the complement cascade, which involves some 20 plasma proteins synthesized mainly in the liver, and completes the process of opsonization. The complement cascade involves the sequential cleavage of the complement proteins into a large fragment, which generally binds to the antigenic surface, and a small bioactive fragment which is released. The final step is the recognition of complement by receptors on the surfaces of neutrophils (and macrophages), which promotes phagocytosis of the organism.

Neutrophils are short-lived; they spend some 6–7 hours circulating in the blood and a few days in connective tissues. The number of circulating neutrophils varies, and often rises during episodes of acute bacterial infection. They die after carrying out their phagocytic role: dead neutrophils, bacteria, tissue debris (including tissue damaged by neutrophil enzymes and toxins) and interstitial fluid form the characteristic, greenish-yellow pus of infected tissue. The colour is derived from the natural colour of neutrophil myeloperoxidase.

Granules may also be inappropriately released from neutrophils. Their enzymes are implicated in various pathological conditions, e.g. rheumatoid arthritis, where tissue destruction and chronic inflammation occur.

Eosinophil granulocytes

Eosinophil granulocytes (eosinophils) are similar in size (12–15 μm), shape and motile capacity to neutrophils, but are present only in small numbers in normal blood (100–400/μl). The nucleus has two prominent lobes connected by a thin strand of chromatin. Their cytoplasmic specific granules are uniformly large (0.5 μm) and give the living cell a slightly yellowish colour. The cytoplasm is packed with granules which are spherical or ellipsoid and membrane-bound. The core of each granule is composed of a lattice of major basic protein, which is responsible for its strong eosinophilic staining properties. The surrounding matrix contains several lysosomal enzymes including acid phosphatase, ribonuclease, phospholipase and a myeloperoxidase unique to eosinophils.

Like other leukocytes, eosinophils are motile. When suitably stimulated, they are able to pass into the extravascular tissues from the circulation. They are typical minor constituents of the dermis, and of the connective tissue components of the bronchial tree, alimentary tract, uterus and vagina. The total lifespan of these cells is a few days, of which some 10 hours is spent in the circulation, and the remainder in the extravascular tissues.

Eosinophil numbers rise (eosinophilia) in worm infestations and also in certain allergic disorders, and it is thought that they evolved as a primary defence against parasitic attack. They have surface receptors for IgE which bind to IgE-antigen complexes, triggering phagocytosis and release of granule contents. However, they are only weakly phagocytic and their most important function is the destruction of parasites too large to phagocytose. This anti-parasitic effect is mediated via toxic molecules released from their granules (e.g. eosinophil cationic protein and major basic protein). They also release histaminase, which limits the inflammatory consequences of mast cell degranulation. High local concentrations of eosinophils, e.g. in bronchial asthma and in cutaneous contact sensitivity and allergic eczema, can cause tissue destruction as a consequence of the release of molecules such as collagenase from their granules.

Basophil granulocytes

Slightly smaller than other granulocytes, basophil granulocytes are 10–14 μm in diameter, and form only 0.5–1% of the total leukocyte population of normal blood, with a count of 25–200/μl. Their distinguishing feature is the presence of large, conspicuous basophilic granules. The nucleus is somewhat irregular or bilobed, and is usually obscured in stained blood smears by the similar colour of the basophilic granules. The granules are membrane-bound vesicles which display a variety of crystalline, lamellar and granular inclusions: they contain heparin, histamine and several other inflammatory agents, and closely resemble those of tissue mast cells (see p. 36). Both basophils and mast cells have high affinity membrane receptors for IgE and are therefore coated with IgE antibody. If this binds to its antigen it triggers degranulation of the cells, producing vasodilation, increased vascular permeability, chemotactic stimuli for other granulocytes, and the symptoms of immediate hypersensitivity, e.g. in allergic rhinitis (hay fever). Despite these similarities, basophils and mast cells develop as separate lineages in the myeloid series, from haemopoietic stem cells in the bone marrow. Evidence from experimental animal models suggests that they are closely related (see Fig. 4.12) but studies on mast cell disorders in humans indicate that their lineages diverge from a more distant ancestral progenitor (Kocabas et al 2005).

Mononuclear leukocytes

Lymphocytes

Lymphocytes (Fig. 4.4, see Fig. 4.6, see Fig. 4.12) are the second most numerous type of leukocyte in adulthood, forming 20–30% of the total population (1500–2700/μl of blood). In young children they are the most numerous blood leukocyte. Most circulating lymphocytes are small, 6–8 μm in diameter; a few are medium-sized and have an increased cytoplasmic volume, often in response to antigenic stimulation. Occasionally, cells up to 16 μm are seen in peripheral blood. Lymphocytes, like other leukocytes, are found in extravascular tissues (including lymphoid tissue); however, they are the only white blood cells which return to the circulation. The lifespan of lymphocytes ranges from a few days (short-lived) to many years (long-lived). Long-lived lymphocytes play a significant role in the maintenance of immunological memory.

Blood lymphocytes are a heterogeneous collection mainly of B and T cells and consist of different subsets and different stages of activity and maturity. About 85% of all circulating lymphocytes in normal blood are T cells. Primary immunodeficiency diseases can result from molecular defects in T and B lymphocytes (reviewed in Cunningham-Rundles & Ponda 2005). Included with the lymphocytes, but probably a separate lineage subset, are the natural killer (NK) cells. NK cells most closely resemble large T cells morphologically.

Small lymphocytes (both B and T cells) contain a rounded, densely staining nucleus which is surrounded by a very narrow rim of cytoplasm, barely visible in the light microscope. In the electron microscope (Fig. 4.4), few cytoplasmic organelles can be seen apart from a small number of mitochondria, single ribosomes, sparse profiles of endoplasmic reticulum and occasional lysosomes: these features indicate a low metabolic rate and a quiescent phenotype. However, these cells become motile when they contact solid surfaces, and can pass between endothelial cells to exit from, or re-enter, the vascular system. They migrate extensively within various tissues, including epithelia (Fig. 4.5).

Larger lymphocytes include T and B cells which are functionally activated or proliferating after stimulation by antigen, and NK cells. They contain a nucleus, which is at least in part euchromatic, a basophilic cytoplasm, which may appear granular, and numerous polyribosome clusters, consistent with active protein synthesis. The ultrastructural appearance of these cells varies according to their class and is described below.

B cells

B cells and the plasma cells that develop from them synthesize and secrete antibodies which can specifically recognize and neutralize foreign (non-self) macromolecules (antigens), and can prime various non-lymphocytic cells (e.g. neutrophils, macrophages and dendritic cells) to phagocytose pathogens. B cells differentiate from haemopoietic stem cells in the bone marrow. After deletion of autoreactive cells, the selected B lymphocytes then leave the bone marrow and migrate to peripheral lymphoid sites (e.g. lymph nodes). Here, following stimulation by antigen, they undergo further proliferation and selection, forming germinal centres in the lymphoid tissues. Following this, some B cells differentiate into large basophilic (RNA-rich) plasma cells, either within or outside the lymphoid tissues. Plasma cells produce antibodies in their extensive rough endoplasmic reticulum (Fig. 4.6) and secrete them into the adjacent tissues. They have a prominent pale-staining Golgi complex adjacent to an eccentrically-placed nucleus, typically with peripheral blocks of condensed heterochromatin resembling the numerals of a clock (clock-faced nucleus) (see Fig. 4.12). Other germinal centre B cells develop into long-lived memory cells capable of responding to their specific antigens not only with a more rapid and higher antibody output, but also with an increased antibody affinity compared with the primary response.

Antibodies are immunoglobulins, grouped into five classes according to their heavy polypeptide chain. Immunoglobulin G (IgG) forms the bulk of circulating antibodies. Immunoglobulin M (IgM) is normally synthesized early in immune responses. Immunoglobulin A (IgA) is present in breast milk, tears, saliva and other secretions of the alimentary tract, coupled to a secretory piece (a 70 kDa protein) which is synthesized by the epithelial cells and protects the immunoglobulin from proteolytic degradation: IgA thus contributes to mucosal immunity. IgA deficiency is relatively common, particularly in some ethnic groups (reviewed in Woof & Kerr 2006). Immunoglobulin E (IgE) is an antibody which binds to receptors on the surfaces of mast cells, eosinophils and blood basophils; it is found only at low concentrations in the circulation. Immunoglobulin D (IgD) is found together with IgM as a major membrane-bound immunoglobulin on mature, immunocompetent but naïve (prior to antigen exposure) B cells, acting as the cellular receptor for antigen.

When circulating antibodies bind to antigens they form immune complexes. If present in abnormal quantities, these may cause pathological damage to the vascular system and other tissues, either by interfering mechanically with the permeability of the basal lamina (e.g. some types of glomerulonephritis), or by causing local activation of the complement system which generates inflammatory mediators (e.g. C5a), attacks cell membranes and causes vascular disease. In pregnancy, maternal IgG crosses the placenta and confers passive immunity on the fetus. Maternal milk contains secretory immunoglobulins (IgA) which help to combat bacterial and viral organisms in the alimentary tract of the baby during the first few weeks of postnatal life.

T cells

There are a number of sub-sets of T (thymus-derived) lymphocytes, all progeny of haemopoietic stem cells in the bone marrow. They develop and mature in the thymus, and subsequently populate peripheral secondary lymphoid organs, which they constantly leave and re-enter via the circulation. As recirculating cells, their major function is immune surveillance. Their activation and subsequent proliferation and functional maturation is under the control of antigen-presenting cells. T cells undertake a wide variety of cell-mediated defensive functions which are not directly dependent on antibody activity, and which constitute the basis of cellular immunity. T cell responses focus on the destruction of cellular targets such as virus-infected cells, certain bacterial infections, fungi, some protozoal infections, neoplastic cells and the cells of grafts from other individuals (allografts) when the tissue antigens of the donor and recipient are not sufficiently similar. Targets may be killed directly by cytotoxic T cells, or indirectly by accessory cells (e.g. macrophages) which have been recruited and activated by cytokine-secreting helper T cells. A third group, regulatory T cells, acts to regulate or limit immune responses.

Functional groups of T cells are classified according to the molecules they express on their surfaces. The majority of cytokine-secreting helper T cells express CD4, while cytotoxic T cells are characterized by CD8. Regulatory T cells coexpress CD4 and CD25. The CD (cluster of differentiation) prefix provides a standard nomenclature for all cell surface molecules. At present, more than 330 different CD antigens have been designated: each one represents a cell surface molecule that can be identified by specific antibodies. Further details of the classification are beyond the scope of this publication and are given in Male et al (2006).

Structurally, T lymphocytes present different appearances depending on their type and state of activity. When resting, they are typical small lymphocytes and are morphologically indistinguishable from B lymphocytes. When stimulated, they become large (up to 15 μm), moderately basophilic cells, with a partially euchromatic nucleus and numerous free ribosomes, rough and smooth endoplasmic reticulum, a Golgi complex and a few mitochondria, in their cytoplasm. Cytotoxic T cells contain dense lysosome-like vacuoles which function in cytotoxic killing.

Helper T cells

Helper T cells (which express CD4) are characterized by the secretion of cytokines. Two major populations have been identified according to the range of cytokines produced. Th1 helper T cells typically secrete interleukin (IL)-2, tumour necrosis factor (TNF)-alpha and interferon gamma, while Th2 cells produce cytokines such as IL-4, IL-5 and IL-13. These two CD4-expressing populations are termed ‘helper’ T cells because one aspect of their function is to stimulate the proliferation and maturation of B lymphocytes and cytotoxic T lymphocytes (mediated via cytokines such as IL-4, IL-2 and interferon gamma), thus enabling and enhancing the immune responses mediated by those cells. In addition to Th1 and Th2 cells, other subsets of helper T cells have been described. Notably, Th17 cells (which secrete the cytokine IL-17) have recently been implicated in autoimmune diseases.

However, helper T cells are also important in directing the destruction of pathogens by recruiting accessory cells (e.g. macrophages, neutrophils, eosinophils) to the site of infection and by activating their effector functions. This process is tightly coordinated. For example, Th1 helper T cells secrete cytokines that not only attract and activate macrophages but also provide help for B cells and guide their immunoglobulin production to the subclasses that fix complement. Thus these antibodies opsonize the pathogen target which can then be recognized, ingested and destroyed by the macrophage accessory cells that bear receptors for complement and the Fc region of IgG. These Th1 cells are sometimes referred to as delayed type hypersensitivity T cells. In contrast, Th2 cells secrete cytokines that induce the development and activation of eosinophils, and also induce B cells to switch their immunoglobulins to non-complement fixing classes (e.g. IgE). Pathogens such as parasitic worms can then be coated with IgE antibody and hence recognized and destroyed by the effector functions of the eosinophil accessory cells which bear receptors for the Fc region of IgE.

If helper T-cell activities are non-functional, a state of immunodeficiency results. This means that potentially pathogenic organisms, which are normally kept in check by the immune system, may proliferate and cause overt pathology, e.g. in acquired immune deficiency syndrome (AIDS), where a virus (HIV) specifically infects and kills (predominantly) helper T cells, though some antigen-presenting cells are also killed.

Regulatory T cells

A third population of T cells, ‘regulatory’ T or ‘Treg’ cells has been identified within the last decade (reviewed in O’Garra & Vieira 2004). These CD4+, CD25+ cells have an immunomodulatory function and can dampen the effector functions of both cytotoxic and helper T cells. Regulatory T cells are produced in the thymus and are an important additional mechanism for maintaining self-tolerance. Treg function is antigen-specific and depends upon direct cell–cell contact. Molecules secreted or induced by Treg cells, such as interleukin (IL)-10 or transforming growth factor (TGF) β, may also play an important role in mediating Treg suppressive effects on the immune system. Similar regulatory T cells can be induced in the periphery and may be important in the induction of oral tolerance to ingested antigens as well as tolerance to tissue specific molecules that are not expressed in the thymus.

Platelets

Blood platelets, also known as thrombocytes, are relatively small (2–4 μm across) irregular or oval discs present in large numbers (200,000–400,000/μl) in blood. In freshly harvested blood samples they readily adhere to each other and to all available surfaces, unless the blood is treated with citrate or other substances which reduce the availability of calcium ions. Platelets are anucleate cell fragments, derived from megakaryocytes in the bone marrow. They are surrounded by a plasma membrane with a thick glycoprotein coat, which is responsible for their adhesive properties. A band of 10 microtubules lies around the perimeter of the platelet beneath the plasma membrane: the microtubules are associated with actin filaments, myosin and other proteins related to cell contraction. The cytoplasm also contains mitochondria, glycogen, scant smooth endoplasmic reticulum, tubular invaginations of the plasma membrane, and three major types of membrane-bound vesicle, designated alpha, delta and lambda granules.

Alpha granules are the largest, and have diameters of up to 500 nm. They contain platelet-derived growth factor (PDGF), fibrinogen and other substances. Delta granules are smaller (up to 300 nm), and contain 5-hydroxytryptamine (serotonin) which has been endocytosed from the blood plasma. Lambda granules are the smallest (up to 250 nm) and contain lysosomal enzymes.

Platelets play an important role in haemostasis. When a blood vessel is damaged, platelets become activated, evert their membrane invaginations to form lamellipodia and filopodia, and aggregate at the site of injury, plugging the wound. They adhere to each other (agglutination), and to other tissues. Adhesion is a function of the thick platelet coat and is promoted by the release of ADP and calcium ions from the platelets in response to vessel injury. The contents of released alpha granules, together with factors released from the damaged tissues, initiate a complex sequence of chemical reactions in the blood plasma, which leads to the precipitation of insoluble fibrin filaments in a three-dimensional meshwork, the fibrin clot (Fig. 4.1). More platelets attach to the clot, inserting extensions of their surfaces, filopodia, deep into the spaces between the fibrin filaments, to which they adhere strongly. The platelets then contract (clot retraction) by actin–myosin interactions within their cytoplasm, and this concentrates the fibrin clot and pulls the walls of the blood vessel together, which limits any further leakage of blood. After repair of the vessel wall, which may be promoted by the mitogenic activity of PDGF, the clot is dissolved by enzymes such as plasmin. Plasmin is formed by plasminogen activators in the plasma, probably assisted by lysosomal enzymes derived from the lambda granules of platelets. Platelets typically circulate for 10 days before they are removed, mainly by splenic macrophages.

LYMPHOID TISSUES

Lymphocytes are located in many sites in the body, most obviously at strategic sites which are liable to infection, e.g. the oropharynx. The main areas of lymphocyte concentration are classified as primary or secondary lymphoid organs, according to whether they are involved in de novo lymphocyte generation (primary lymphoid organs, e.g. bone marrow, thymus) or the site of mature lymphocyte activation and initiation of an immune response (secondary lymphoid organs, e.g. lymph nodes, spleen).

All lymphocytes arise from pluripotent haemopoietic stem cells in the bone marrow. The B lymphocyte lineage develops through a series of differentiation stages within the bone marrow. The newly formed B cells then leave through the circulation and migrate to peripheral sites. In contrast, T lymphocyte development requires the thymus; the bone marrow-derived stem cells must therefore migrate via the blood circulation to the thymus. After their differentiation and maturation into immunocompetent T cells which have survived thymic selection processes (1–3%), they re-enter the circulation and are transported to peripheral sites where they join the pool of naïve lymphocytes which recirculate through the secondary lymphoid organs via blood and lymphatic circulation systems.

The secondary or peripheral lymphoid organs are the specialized sites where B and T lymphocytes and antigen presenting cells come together to initiate immune responses to foreign antigens. These secondary tissues include lymph nodes, spleen, and lymphoid tissue associated with epithelial surfaces (mucosa-associated lymphoid tissue, MALT), e.g. the palatine and nasopharyngeal tonsils, Peyer’s patches in the small intestine, lymphoid nodules in the respiratory and urogenital systems, the skin and conjunctiva of the eye. The microstructure of lymph nodes and of general MALT are described below. Details of all other lymphoid tissues and organs are included in the descriptions of the appropriate regional anatomy.

Lymphocytes enter secondary lymphoid tissues from the blood, usually by migration through the walls of capillaries or venules (high endothelial venules, HEV) and leave by the lymphatic system. In the spleen, lymphocyte entry and exit is via the marginal zone and venous drainage respectively. Antigen presenting cells (dendritic cells) enter via the lymphatics, bringing with them antigen from peripheral infected sites. In all the secondary tissues there are specific areas where either B or T cells are concentrated. After activation, functionally competent lymphocytes migrate to other sites in the body, where they combat the original infection.

LYMPH NODES

Lymph nodes (Fig. 4.7) are encapsulated centres of antigen presentation and lymphocyte activation, differentiation and proliferation. They generate mature, antigen-primed, B and T cells, and filter particles, including microbes, from the lymph by the action of numerous phagocytic macrophages. A normal young adult body contains up to 450 lymph nodes, of which 60–70 are found in the head and neck, 100 in the thorax and as many as 250 in the abdomen and pelvis. Lymph nodes are particularly numerous in the neck, mediastinum, posterior abdominal wall, abdominal mesenteries, pelvis and proximal regions of the limbs (axillary and inguinal lymph nodes). By far the greatest number lie close to the viscera, especially in the mesenteries.

Microstructure

Lymph nodes (Fig. 4.8) are small, oval or kidney-shaped bodies, 0.1–2.5 cm long, lying along the course of the lymphatic vessels. Each usually has a slight indentation on one side, the hilum, through which blood vessels enter and leave and the efferent lymphatic vessel leaves. Several afferent lymphatic vessels enter the capsule around the periphery. Lymph nodes have a highly cellular cortex and a medulla which contains a network of minute lymphatic channels (sinuses) through which lymph from the afferent lymphatics is filtered, to be collected at the hilum by the efferent lymphatic. The cortex is absent at the hilum, where the medulla reaches the surface.

The capsule is composed mainly of collagen fibres, elastin fibres (especially in the deeper layers), and a few fibroblasts. From the capsule, trabeculae of dense connective tissue extend radially into the interior of the node. They are continuous with a network of fine type III collagen (reticulin) fibrils which supports the lymphoid tissue. At the hilum, dense fibrous tissue may extend into the medulla, surrounding the efferent lymphatic vessel.

The fine reticulin bundles branch and interconnect to form a very dense network in the cortex: there are fewer fibres in the germinal centres of follicles (see below). They provide attachment for various cells, mostly dendritic cells, macrophages and lymphocytes. Reticulin and the associated proteoglycan matrix are produced by fibroblasts, a few of which are associated with the fibre network.

Lymphatic and vascular supply

Lymph nodes are permeated by channels through which lymph percolates after its entry from the afferent vessels. Macrophages line the channels or migrate along the reticulin which crosses them, and so lymph is exposed to their phagocytic activities, as well as to B and T lymphocytes which lie within the various regions of a node. Afferent lymphatic vessels enter at many points on the periphery, branch to form a dense intracapsular plexus, and then open into the subcapsular sinus, a cavity which is peripheral to the whole cortex except at the hilum (Fig. 4.7). Numerous radial cortical sinuses lead from the subcapsular sinus to the medulla, where they coalesce as larger medullary sinuses. The latter become confluent at the hilum with the efferent vessel which drains the node. All of these spaces are lined by a continuous endothelium and traversed by fine reticular fibres, which support sinus macrophages.

Arteries and veins serving lymph nodes pass through the hilum, giving off straight branches which traverse the medulla, and sending out minor branches as they do so. In the cortex, arteries form dense arcades of arterioles and capillaries in numerous anastomosing loops, eventually returning to highly branched venules and veins. Capillaries are especially profuse around the follicles, which contain fewer vessels. Postcapillary HEV are abundant in the paracortical zones. They form an important site of blood-borne lymphocyte extravasation into lymphoid tissue, apparently by migration through labile endothelial tight junctions. The density of the capillary beds increases greatly when lymphocytes multiply in response to antigenic stimulation. Veins leave a node through its principal trabeculae and capsule, and drain them and the surrounding connective tissue.

Cells and cellular zones of lymph nodes

Although most of the cells in a lymph node are B and T lymphocytes, their distribution is not homogeneous. In the cortex, cells are densely packed and in the outer cortical area they form lymphoid follicles or nodules (Fig. 4.8), which are populated mainly by B cells and specialized follicular dendritic cells (FDC) (see Fig. 4.15). The number, degree of isolation and staining characteristics of follicles vary according to their state of antigenic stimulation. A primary follicle is uniformly populated by small, quiescent lymphocytes, whereas a secondary follicle has a germinal centre (Fig. 4.9) which is composed mainly of antigen-stimulated B cells which are larger, less deeply staining and more rapidly dividing than those at its periphery.

The role of the germinal centre is to provide a microenvironment which allows the affinity maturation of the B cell response, so that as the immune response progresses the affinity or strength with which antibodies bind their antigen also increases. There are several zones in the germinal centre where this is allowed to happen. In the ‘dark zone’ the B cells (centroblasts) undergo rapid proliferation which is associated with hypermutation of their antibody molecules. They then move into the light zone (as centrocytes), where they can interact with the FDCs which carry intact unprocessed antigen on their surface. The centrocytes compete for binding to the antigen; those whose antibody has the highest affinity survive and the rest die. T cells are also present, helping the survival of the B cells and inducing class switching. Macrophages in the germinal centre phagocytose apoptotic lymphocytes (e.g. those B cells which die as part of the process of affinity maturation), and consequently macrophage cytoplasm becomes filled with engulfed lipid and nuclear debris.

The mantle zone (Fig. 4.9) is produced as surrounding cells are marginalized by the rapidly growing germinal centre. It is populated by cells similar to those found in primary follicles, mainly quiescent B cells with condensed heterochromatic nuclei and little cytoplasm (hence the deeply basophilic staining of this region in routine preparations; Fig. 4.10), a few helper T cells, FDCs and macrophages. After numerous mitotic divisions the selected B cells give rise to small lymphocytes, some of which become memory B cells and leave the lymph node to join the recirculating pool, while others leave to mature as antibody-secreting plasma cells either in the lymph node medulla or in peripheral tissues.

The deep cortex or paracortex lies between the cortical follicles and the medulla, and is populated mainly by T cells, which are not organized into follicles. Both CD4 and CD8 T cell subsets are present. The paracortex also contains interdigitating dendritic cells. These dendritic cells include Langerhans cells from the skin and other squamous epithelia which have migrated as veiled cells via the afferent lymphatics into the draining lymph nodes (see Fig. 4.14). Their role is to present processed antigen to T cells. The region expands greatly in T cell-dominated immune responses, when its cells are stimulated to proliferate and disperse to peripheral sites.

In the medulla, lymphocytes are much less densely packed, forming irregular, branching medullary cords between which the reticulin network is easily seen. Other cells include macrophages, which are more numerous in the medulla than in the cortex, plasma cells and a few granulocytes.

MUCOSA-ASSOCIATED LYMPHOID TISSUE (MALT)

Large amounts of unencapsulated lymphoid tissue exist in the walls of the alimentary, respiratory, reproductive and urinary tracts, and in the skin: they are collectively termed mucosa-associated lymphoid tissue (MALT). Some authorities distinguish between lymphoid tissues associated with different organ systems of the body. Although there may be functional differences between them related to the different antigenic challenges encountered, this is not evident in their microstructure. Anatomically, the main subclasses are gut-associated lymphoid tissue (GALT) and bronchus-associated lymphoid tissue (BALT).

Throughout the body, MALT includes an extremely large population of lymphocytes, principally because of the size of the alimentary tract. The lymphoid cells are located in the lamina propria and in the submucosa as discrete follicles or nodules. More scattered cells, derived from these follicles, are found throughout the lamina propria and in the base of the epithelium (Fig. 4.5, Fig. 4.10). MALT includes macroscopically visible lymphoid masses, notably the peripharyngeal lymphoid (Waldeyer’s) ring of tonsillar tissue (palatine, nasopharyngeal, tubal and lingual), and the Peyer’s patches of the small intestine (see Ch. 66) which are described elsewhere. Most MALT consists of microscopic aggregates of lymphoid tissue, and lacks a fibrous capsule. Lymphocyte populations are supported mechanically by a fine network of fine type III collagen (reticulin) fibres and associated fibroblasts, as they are in lymph nodes.

In common with lymph nodes, MALT provides centres for the activation and proliferation of B and T lymphocytes in its follicles and parafollicular zones, respectively. The function of cells in these zones, including antigen presenting cells (follicular dendritic cells and interdigitating dendritic cells) and macrophages as well as T and B cells, is similar to that found in lymph nodes. The close proximity of lymphocytes within the MALT to an epithelial surface facilitates their access to pathogens. The lymphocyte population in MALT is not fixed: lymphocytes migrate into MALT through its HEV and leave mainly via its efferent lymphatics, which drain interstitial fluid as lymph. MALT lacks afferent lymphatic vessels. Migration from MALT follows a different route from the major peripheral route of recirculation. After antigen activation, lymphocytes travel via the regional lymph nodes to disperse widely along mucosal surfaces to provide protective T- and B-cell immunity.

HAEMOPOIESIS

Postnatally, blood cells are formed primarily in the bone marrow. Other tissues, particularly the spleen and liver, may develop haemopoietic activity once more, if production from the marrow is inadequate.

BONE MARROW

Bone marrow is a soft pulpy tissue which is found in the marrow cavities of all bones (Fig. 4.11) and even in the larger Haversian canals of lamellar bone. It differs in composition in different bones and at different ages and occurs in two forms, yellow and red marrow. In old age the marrow of the cranial bones undergoes degeneration and is then termed gelatinous marrow.

Red marrow

Red marrow is found throughout the skeleton in the fetus and during the first years of life. After about the fifth year the red marrow, which represents actively haemopoietic tissue, is gradually replaced in the long bones by yellow marrow. The replacement starts earlier, and is generally more advanced, in the more distal bones. By 20–25 years of age, red marrow persists only in the vertebrae, sternum, ribs, clavicles, scapulae, pelvis, cranial bones and in the proximal ends of the femur and humerus.

Red bone marrow consists of a network of loose connective tissue, the stroma, which supports clusters of haemopoietic cells (haemopoietic cords or islands) and a rich vascular supply in which large, thin-walled sinusoids are the main feature (Fig. 4.11). The vascular supply is derived from the nutrient artery to the bone, which ramifies in the bone marrow, and terminates in thin-walled arterioles from which the sinusoids arise. These, in turn, drain into disproportionately large veins. Lymphatic vessels are absent from bone marrow. The stroma contains a variable amount of fat, depending on age, site and the haematological status of the body, and small patches of lymphoid tissue are also present. Marrow thus consists of vascular and extravascular compartments, both enclosed within a bony framework from which they are separated by a thin layer of endosteal cells (p. 91).

CELL LINEAGES

Haemopoietic stem cells

Within the adult marrow there is a very small number (0.05% of haemopoietic cells) of self-renewing, pluripotent stem cells which are capable of giving rise to all blood cell types, including lymphocytes (Fig. 4.12). Although they cannot be identified morphologically in the marrow, they can be recognized in aspirates by the expression of specific cell surface marker proteins (e.g. CD34). It is thought that haemopoietic stem cells occupy specific environmental niches in the marrow associated with the endosteum of trabecular bone or with sinusoidal endothelium and that their microenvironment is important in homeostasis, the balance between self-renewal and differentiation. Stem cells can also be found (at lower concentrations) in the peripheral blood, particularly after treatment with appropriate cytokines.

Progressively more lineage-restricted committed progenitor cells develop from these ancestors (see Laiosa et al 2006 for a recent review) to produce the various cell types found in peripheral blood. The committed progenitor cells are often termed colony-forming units (CFU) of the lineage(s), e.g. CFU-GM cells give rise, after proliferation, to neutrophil granulocytes, monocytes and certain dendritic cells, whereas CFU-E produce only erythrocytes. Each cell type undergoes a period of maturation in the marrow, often accompanied by several structural changes, before release into the general circulation. In some lineages, e.g. the erythroid series, the final stages of maturation take place in the circulation, whereas in the monocytic lineage, they occur after the cells have left the circulation and entered peripheral tissues where they differentiate into macrophages and some dendritic cells.

To generate a complete set of blood cells from a single pluripotent cell may take some months. The later progenitor cells form mature cells of their particular lineages more quickly. However, because they are not self-renewing, grafts of these later cells eventually fail because the cells they produce all ultimately die. This is of considerable importance in bone marrow replacement therapy. The presence of pluripotent stem cells in the donor marrow is essential for success: only 5% of the normal number are needed to repopulate the marrow. Following replacement therapy, T lymphocytes reconstitute more slowly than the other haemopoietic lineages, reflecting the progressive reduction in size of the thymus with age (chronic involution).

Lymphocytes

Lymphocytes are a heterogeneous group of cells which may share a common ancestral lymphoid progenitor cell, distinct from the myeloid progenitor cell which gives rise to all of the cell types described above. The first identifiable progenitor cell is the lymphoblast, which divides several times to form prolymphocytes: both cells are characterized by a high nuclear to cytoplasmic ratio. B cells undergo differentiation to their specific lineage subset entirely within the bone marrow and migrate to peripheral or secondary lymphoid tissues as naïve B cells, ready to respond to antigen. However, T cells require the specialized thymic microenvironment for their development. During fetal and early postnatal life, and subsequently at lower levels throughout life, progenitor cells migrate to the thymus where they undergo a process of differentiation and selection as T cells, before leaving to populate secondary lymphoid tissues.

T-cell (thymocyte) development

T cells develop within the thymus from blood-borne bone marrow-derived progenitors which enter the thymus via HEVs at the corticomedullary junction. They first migrate to the outer (subcapsular) region of the thymic cortex and then, as in the bone marrow, move progressively inwards towards the medulla as development continues. T-cell development involves gene rearrangements in the T-cell receptor (TcR) loci to create unique receptors for antigen on each cell, together with the progressive expression of molecules required for mature T-cell function. Selection of the receptor repertoire is more stringent for T cells than for B cells because of the way in which mature T cells recognize cell-bound antigens presented in conjunction with specific proteins of the major histocompatibility complex (MHC) expressed on the surfaces of cells. Thus mature CD8 (cytotoxic) T cells recognize antigen in the form of short peptides complexed with the polymorphic MHC class I molecules, while CD4 (helper/regulatory) T cells recognize the peptides in the context of MHC class II molecules. Because the TcR recognizes both the peptide and the MHC molecule, the T cell will only recognize peptides bound to their own (self) type of MHC: they will not ‘see’ peptides in combination with allelically different MHC molecules (i.e. those from other individuals). This is termed MHC restriction of T-cell recognition. Selection of T cells in the thymus must ensure the survival of those T cells which can respond only to foreign antigens, bound to their own (self) class of MHC molecule. Cells which are incapable of binding to self MHC molecules, or which bind to self-antigens, are eliminated by apoptotic cell death: it is estimated that up to 95% of T cell progenitors undergo apoptosis in this way. Cells which express an appropriate TcR and have effective MHC-restricted binding properties survive to become mature, naïve T cells which leave the thymus and populate the periphery.

Thymic stromal cells play a crucial role in T-cell development and selection. Thymic epithelial cells in the cortex express both MHC class I and II molecules and are unique in their ability to select T cells which recognize self MHC (positive selection). Deletion of self-antigen reactive cells (negative selection) is mainly controlled by thymic dendritic cells located at the corticomedullary junction and in the medulla, although the epithelium can also perform this function. Apoptotic thymocytes are removed by thymic macrophages. The role of the thymic epithelium in thymocyte differentiation is complex and involves cell–cell contact as well as the secretion of soluble mediators such as cytokines, chemokines, neuroactive peptides (e.g. somatostatin) and thymic hormones (e.g. thymulin). Thymic fibroblasts and the extracellular matrix also play a role.

Erythrocytes

Erythrocytes and granulocytes belong to the myeloid lineage. The earliest identifiable erythroid progenitor cells are capable of rapid bursts of cell division to form numerous daughter cells; they have thus been named burst-forming units of the erythroid line (BFU-E). They give rise to the CFU-E, which, with their immediate progeny, are sensitive to the hormone erythropoietin. This hormone, produced in the kidney, induces further differentiation along the erythroid line.

The first readily identifiable cell of the erythroid series is the proerythroblast, which is a large (about 20 μm) cell with a large euchromatic nucleus and a moderately basophilic cytoplasm. It also responds to erythropoietin. The proerythroblast contains small amounts of ferritin and bears some of the protein spectrin on its plasma membrane. Proerythroblasts proliferate to produce smaller (12–16 μm) basophilic erythroblasts, rich in ribosomes, in which haemoglobin-RNA synthesis begins. The cytoplasm becomes partially, and then uniformly, eosinophilic (the polychromatic erythroblast and orthochromatic erythroblast respectively). These cells are only 8–10 μm in diameter and contain very little cytoplasmic RNA. The nucleus becomes pyknotic (dense, deep-staining, shrunken) and is finally extruded from the cell, leaving an anucleate reticulocyte, which enters a sinusoid. Its reticular staining pattern, visible using special stains, results from residual cytoplasmic RNA which is usually lost within 24 hours of entering the peripheral blood circulation. Reticulocyte numbers in peripheral blood are therefore a good indicator of the rate of red cell production. The whole process of erythropoiesis takes 5–9 days.

Granulocytes

Granulocyte formation involves major changes in nuclear morphology and cytoplasmic contents which are best known for the neutrophil. Initially, myeloid progenitor cells transform into large (10–20 μm) myeloblasts which are similar in general size and appearance to proerythroblasts. These proliferative cells have large euchromatic nuclei and lack cytoplasmic granules. They differentiate into slightly larger promyelocytes, in which the first group of specific proteins is synthesized in the rough endoplasmic reticulum and Golgi apparatus. The proteins are stored in large (0.3 μm) primary (non-specific) granules, which are large lysosomes containing acid phosphatase. Smaller secondary (specific) granules are formed in the smaller myelocyte, which is the last proliferative stage. The nucleus is typically flattened or slightly indented on one side in myelocytes.

In the next, metamyelocyte, stage, the cell size (10–15 μm) decreases, the nucleus becomes heterochromatic and horse-shoe shaped, and protein synthesis almost stops. As the neutrophil is released, the nucleus becomes first heavily indented (the juvenile stab or band form), and subsequently segmented into up to six lobes, characteristic of the mature neutrophil. The whole process usually takes 7 days to complete, of which 3 days are spent proliferating, and 4 days maturing. Neutrophils may then be stored in the marrow for a further 4 days, depending on demand, before their final release into the circulation.

Eosinophils and basophils pass through a similar sequence but their nuclei do not become as irregular as that of the neutrophil. It is thought that these cells each arise from distinct colony-forming units, which are separate from the CFU-GM.

PHAGOCYTES AND ANTIGEN-PRESENTING CELLS

Macrophages and neutrophils (see above) are specialized phagocytes. Certain dendritic cells (see Fig. 4.12), e.g. Langerhans cells of the skin and other stratified squamous epithelia, are ‘professional’ antigen-presenting cells (APCs): they take up foreign material by endocytosis and macropinocytosis, and are uniquely capable of efficiently activating naïve as well as mature T lymphocytes. Macrophages are also able to process and present antigen to lymphocytes, but are less effective than dendritic cells. In addition they play an important role in the effector arm of the immune response, clearing the infectious agent by phagocytosis. The third major cell type involved in antigen presentation and T cell activation is the B lymphocyte, which is particularly efficient at taking up antigen that binds to its surface immunoglobulin (see above). Follicular dendritic cells of lymph nodes, MALT and the spleen are capable of presenting non-processed antigen to B lymphocytes, but are not classic APCs because they cannot present antigen to helper T cells.

APCs endocytose antigen, digest it intracellularly, mostly to peptide fragments, and present the fragments on their surfaces, generally in conjunction with MHC class II molecules. (Class II molecules are normally found only on APCs, although many other cells can express class II molecules in inflammatory situations.) Recognition of foreign antigen is controlled by a variety of APC cell surface receptors: Fc and complement receptors mediate uptake of opsonized material, while pattern recognition receptors of the innate immune system, e.g. Toll-like receptors and scavenger receptors, directly recognize pathogen-derived molecules.

MACROPHAGES

The mononuclear phagocyte system consists of the blood monocytes, from which the other types are derived, and various tissue macrophages, some of which have tissue-specific names. Certain dendritic cells are sometimes included in the mononuclear phagocyte system: although they share a common lineage ancestor, they appear to form a discrete branch of the family tree. Most monocytes and macrophages express class II MHC molecules.

Macrophages are very variable in size (generally 15–25 μm) and are found in many tissues of the body, where they constitute a heterogeneous family of cells (reviewed in Gordon & Taylor 2005). They are migrant cells in all general connective tissues, the alveolar macrophages in the lung, Kupffer cells in liver sinusoids, in bone marrow and in all lymphoid tissues. Macrophages often aggregate in subserous connective tissue of the pleura and peritoneum, where they are visible as milky spots near small lymphatic trunks. They cluster around the terminations of small (penicillar) arterioles in the spleen and are distributed, more diffusely, throughout the splenic cords.

Osteoclasts (up to 100 μm) in bone are closely related to macrophages. However they are syncytial cells derived from the fusion of up to 30 progenitor monocytes in bone tissue, where they differentiate further. Microglia of the central nervous system (CNS) are thought to be monocytic in origin: they migrate into the CNS during its development. They differ from macrophages in that normally they are quiescent cells in which MHC class II expression is downregulated, and they display little phagocytic activity.

Macrophages vary in structure depending on their location in the body. All have a moderately basophilic cytoplasm containing some rough and smooth endoplasmic reticulum, an active Golgi complex and a large, euchromatic and somewhat irregular nucleus. These features are consistent with an active metabolism: synthesis of lysosomal enzymes continues in mature cells. All macrophages have irregular surfaces with protruding filopodia and they contain varying numbers of endocytic vesicles, larger vacuoles and lysosomes. Some macrophages are highly motile, whereas others tend to remain attached and sedentary, e.g. in hepatic and lymphoid sinuses. Within connective tissues, macrophages may fuse to form large syncytia (giant cells) around particles which are too large to be phagocytosed, or when stimulated by the presence of infectious organisms, e.g. Mycobacterium tuberculosis.

When blood-borne monocytes enter the tissues through the endothelial walls of capillaries and venules, they can undergo a limited number of rounds of mitosis as tissue macrophages before they die and are replaced from the bone marrow, typically after several weeks. There is some evidence that alveolar macrophages of the lung are able to undergo many more mitoses than other macrophages.

Phagocytosis

The uptake of particulate material and microorganisms is carried out by macrophages in many tissues and organs. When present in general connective tissue, they ingest and kill invading microorganisms and remove debris that has been produced as a consequence of tissue damage. They recognize, engulf and rapidly ingest apoptotic cells in all situations: the mechanism of apoptotic cell uptake does not activate the phagocyte for antigen presentation, and so the process is immunologically silent. In the lung, alveolar macrophages constantly patrol the respiratory surfaces, to which they migrate from pulmonary connective tissue (Fig. 4.13). They engulf inhaled particles including bacteria, surfactant and debris and many enter the sputum (hence their alternative names, dust cells or, in cardiac disease, heart failure cells, which are full of extravasated erythrocytes). They perform similar scavenger functions in the pleural and peritoneal cavities. In lymph nodes, macrophages line the walls of sinuses and remove particulate matter from lymph as it percolates through them. In the spleen and liver, macrophages are involved in particle removal and in the detection and destruction of aged or damaged erythrocytes. They begin the degradation of haemoglobin for recycling iron and amino acids.

Macrophages bear surface receptors for the Fc portions of antibodies and for the C3 component of complement. Phagocytic activity is greatly increased when the target has been coated in antibody (opsonized) or complement, or both. Once phagocytosis has occurred, the vacuole bearing the ingested particle fuses with endosomal vesicles which contain a wide range of lysosomal enzymes, including many hydrolases, and oxidative systems capable of rapid bacteriocidal action. These activities are much enhanced when macrophages are stimulated (activated macrophages) by cytokines, e.g. interferon (IFN)-γ, which are secreted by other cells of the immune system, especially T lymphocytes.

Close antibody-mediated binding may initiate the release of lysosomal enzymes onto the surfaces of the cellular targets to which the macrophages bind. This process of cytotoxicity is also used by other cells, including neutrophils and eosinophils, particularly if the targets are too large to be phagocytosed (e.g. nematode worm parasites).

DENDRITIC CELLS

There are two distinct groups of dendritic cell, myeloid dendritic cells (also known as conventional dendritic cells) and plasmacytoid dendritic cells. Both groups of cells are derived from haematopoietic stem cells. Until recently it was thought that plasmacytoid dendritic cells were derived from the lymphoid precursor cells, while the myeloid dendritic cells were derived from the myeloid progenitor cell. However, it is now apparent that these cells can be derived from either lineage, possibly from a common stem cell indicating considerable plasticity in their developmental pathways. Both cells are involved in antigen presentation, though have somewhat different functional roles in controlling both the adaptive and innate immune system. The myeloid dendritic cells are professional antigen-presenting cells (APC), which are able to process and present antigen to T lymphocytes, including naïve T cells. They are present as immature dendritic cells in the epidermis of the skin (Fig. 4.14) and other stratified squamous epithelia, e.g. the oral mucosa (Langerhans cells), and in the dermis and most other tissues (interstitial dendritic cells), where they are concerned with immune surveillance. Immature dendritic cells have an antigen-capturing function. They respond to chemotactic signals, for example defensins released by epithelial cells in the small intestine and they express pattern recognition receptors (e.g. Toll-like receptors) on their surface. Binding of bacterial molecules (e.g. carbohydrate or DNA) to these receptors stimulates the dendritic cells to migrate via the lymphatics to nearby secondary lymphoid tissues where they mature and acquire an antigen-presenting function. Mature dendritic cells are known as veiled cells when in the afferent lymphatics and the subcapsular sinuses of lymph nodes, and as interdigitating dendritic cells once they are within the lymphoid tissue proper. Their function within the secondary lymphoid tissue is to present their processed antigen to T lymphocytes, and thus to initiate and stimulate the immune response. For a review of recent research on dendritic cell function, see Colonna et al (2006).

Langerhans cells

Langerhans cells (Fig. 4.14) are one of the most well-studied types of immature dendritic cell (reviewed in Berger et al 2006). They are present throughout the epidermis of skin, where they were first described, but are most clearly identifiable in the stratum spinosum (see Ch. 7). They have an irregular nucleus and a clear cytoplasm, and contain characteristic elongated membranous vesicles (Birbeck granules). Langerhans cells endocytose and process antigens, undergoing a process of maturation from antigen-capturing to antigen-presenting cells which express high levels of MHC class I and II molecules, co-stimulatory molecules and adhesion molecules. They migrate to lymph nodes to activate T lymphocytes.

Follicular dendritic cells

Follicular dendritic cells, FDCs (Fig. 4.15), are a non-migratory population of cells found in the follicles of secondary lymphoid tissues, where they attract and interact with B cells. Unlike other dendritic cells, FDCs are not haemopoietic in origin, but are probably derived from the stromal cells of lymphoid tissues. They are unable to endocytose and process antigen, and they lack MHC class II molecules. However, Fc receptors and complement receptors CD21 and CD35 on FDCs allow the cells to bind immune complexes to their surface for subsequent presentation, as unprocessed antigen, to germinal centre B cells. Interactions between B cells, CD4 helper T cells and FDCs in the germinal centres are important in the selection of high affinity B cells and their maturation to either plasma cells or memory B lymphocytes.

REFERENCES

Berger CL, Vasquez JG, Shofner J, Mariwalla K, Edelson RL. Langerhans cells: mediators of immunity and tolerance. Int J Biochem Cell Biol. 2006;38:1632-1636.

Colonna M, Pulendran B, Iwasaki A. Dendritic cells at the host–pathogen interface. Nature Immunol. 2006;7:117-120.

Cunningham-Rundles C, Ponda PP. Molecular defects in T- and B-cell primary immunodeficiency diseases. Nature Rev Immunol. 2005;5:880-892.

Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol. 2005;5:953-964.

Janeway C, Walport M, Travers P. Immunobiology: The Immune System in Health and Disease, 5th edn. New York: Garland Publishing, 2004.

Emphasizes the unifying principles of structure and function of the immune system in health and disease..

Kocabas CN, Yavuz AS, Lipsky PE, Metcalfe DD, Akin C. Analysis of the lineage relationship between mast cells and basophile using the c-kit D816V mutation as a biologic signature. J Allergy Clin Immunol. 2005;115:1155-1161.

Laiosa CV, Stadtfelt M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Ann Rev Immunol. 2006;24:705-738.

Liu Y-J. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 2001;106:259-262.

Review of current research and a re-evaluation of the lineage of and functional relationships between different dendritic cell types..

Male D, Brostoff J, Roth DB, Roitt I. Immunology, 7th edn. London: Mosby, 2006.

Sets out the scientific principles of clinical immunology, integrated with histology, pathology and clinical examples..

O’Garra A, Vieira P. Regulatory T cells and mechanisms of immune system control. Nat Med. 2004;10:801-805.

Sun L, Hwang WYK, Aw SE. Biological characteristics of megakaryocytes: specific lineage commitment and associated disorders. Int J Biochem Cell Biol. 2006;38:1821-1826.

VIvier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nature Immunol. 2008;9:503-510.

Woof JM, Kerr MA. The function of immunoglobulin A in immunity. J Path. 2006;208:270-282.

Share this: